Canada Biotechnology & Medical Research

Eupraxia Pharmaceuticals Inc (EPRX)

Track

Track

Eupraxia Pharmaceuticals Inc. recorded one notable insider trading transaction over the past ninety days, involving a director purchase valued at approximately 150,033 USD. This activity follows the company's August 2026 results financiers. The stock price has appreciated 27.6 percent during this period, currently trading near its fifty-two-week high.
Ticker: EPRX Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eupraxia Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Montalbano, John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
211.68
Quantity 13,740 -7.0%
Value US$28,922
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
106.98
Quantity 11,383 -46.8%
Value CA$2,564,514
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
264.25
Quantity 37,090 +46.7%
Value CA$2,323,864
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.44
Quantity 2,000 +5.4%
Value CA$18,880
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.40
Quantity 2,000 +5.7%
Value CA$18,800
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.39
Quantity 2,500 +7.7%
Value CA$23,475
3.0
Geyer, Paul Director of Issuer Non-Executive Director
Transaction date
Sale
Price
10.80
Quantity 15,000 -30.8%
Value CA$162,000
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.65
Quantity 1,800 +5.1%
Value CA$19,169
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.72
Quantity 4,200 +59.7%
Value CA$45,003
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 1,929 +5.2%
Value CA$21,026
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.83
Quantity 1,300 +3.7%
Value CA$14,084
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.89
Quantity 1,700 +0.5%
Value CA$18,519
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.91
Quantity 1,800 +0.5%
Value CA$19,638
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.88
Quantity 400 +0.1%
Value CA$4,352
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.17
Quantity 3,874 +11.7%
Value CA$39,386
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 1,700 +0.1%
Value CA$18,533
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 142,858 +9.6%
Value US$1,000,006
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.59
Quantity 125,622 +9.2%
Value CA$1,204,715
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.59
Quantity 7,037
Value CA$60,448
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.59
Quantity 4,483 +1.4%
Value CA$42,992
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-19 B Purchase
3.5
Montalbano, John

Director of Issuer

Non-Executive Director
13,740 -7.0%
211.68
US$28,922 		13,740 -7.0% 211.68 US$28,922
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
11,383 -46.8%
106.98
CA$2,564,514 		11,383 -46.8% 106.98 CA$2,564,514
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
37,090 +46.7%
264.25
CA$2,323,864 		37,090 +46.7% 264.25 CA$2,323,864
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,000 +5.4%
9.44
CA$18,880 		2,000 +5.4% 9.44 CA$18,880
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,000 +5.7%
9.40
CA$18,800 		2,000 +5.7% 9.40 CA$18,800
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,500 +7.7%
9.39
CA$23,475 		2,500 +7.7% 9.39 CA$23,475
2026-03-18 2026-03-18 S Sale
3.0
Geyer, Paul

Director of Issuer

Non-Executive Director
15,000 -30.8%
10.80
CA$162,000 		15,000 -30.8% 10.80 CA$162,000
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +5.1%
10.65
CA$19,169 		1,800 +5.1% 10.65 CA$19,169
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,200 +59.7%
10.72
CA$45,003 		4,200 +59.7% 10.72 CA$45,003
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,929 +5.2%
10.90
CA$21,026 		1,929 +5.2% 10.90 CA$21,026
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,300 +3.7%
10.83
CA$14,084 		1,300 +3.7% 10.83 CA$14,084
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.5%
10.89
CA$18,519 		1,700 +0.5% 10.89 CA$18,519
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +0.5%
10.91
CA$19,638 		1,800 +0.5% 10.91 CA$19,638
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
400 +0.1%
10.88
CA$4,352 		400 +0.1% 10.88 CA$4,352
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
3,874 +11.7%
10.17
CA$39,386 		3,874 +11.7% 10.17 CA$39,386
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.1%
10.90
CA$18,533 		1,700 +0.1% 10.90 CA$18,533
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
142,858 +9.6%
7.00
US$1,000,006 		142,858 +9.6% 7.00 US$1,000,006
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
125,622 +9.2%
9.59
CA$1,204,715 		125,622 +9.2% 9.59 CA$1,204,715
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
7,037
8.59
CA$60,448 		7,037 8.59 CA$60,448
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,483 +1.4%
9.59
CA$42,992 		4,483 +1.4% 9.59 CA$42,992
Explore more

More insider trading research around Eupraxia Pharmaceuticals Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America